Genetic Contributions to Acquired Epilepsies
Piero Perucca1,2,3, Ingrid E Scheffer4,5,6
1Department of Neuroscience, Central Clinical School, 161666Monash University, Melbourne, Victoria, Australia.
Epilepsy Currents
|September 29, 2020
Summary
Genetic factors may play a role in acquired epilepsies. This review critically examines emerging evidence supporting genetic contributions to seizure development after brain injury.
Area of Science:
- Neuroscience
- Genetics
- Epileptology
Background:
- The role of genetic factors in acquired epilepsies remains a debated topic.
- A minority of individuals develop unprovoked seizures despite similar brain insults, suggesting underlying susceptibility.
- Recent research has begun to provide evidence for genetic contributions.
Purpose of the Study:
- To critically review and appraise the emerging evidence for genetic factors in acquired epilepsies.
- To synthesize findings from recent studies investigating the genetic basis of post-insult seizures.
- To provide an overview of the current state of research in this field.
Main Methods:
- Systematic literature review of studies on genetic contributions to acquired epilepsies.
- Critical appraisal of evidence from relevant published research.
- Synthesis of findings from selected studies.
Main Results:
- Emerging evidence suggests a potential genetic component in the development of acquired epilepsies.
- Studies indicate that genetic predisposition may influence seizure development following brain injury.
- The review consolidates findings that support the hypothesis of genetic susceptibility.
Conclusions:
- Genetic factors likely contribute to the development of acquired epilepsies.
- Further research is warranted to fully elucidate the genetic underpinnings of these conditions.
- Understanding genetic contributions may lead to improved diagnostic and therapeutic strategies.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
993
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
993
01:13Seizures: Classification
1.1K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.0K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.0K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
671
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
671
01:14Antiepileptic Drugs: Glutamate Antagonists
749
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
749
01:28Human Genetics
1.2K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.2K